Annals of Hepatology
Издатель: Elsevier · ISSN 1665-2681 · 90 статей
- The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late?
- Patient-Centred Sleep Outcome Definitions in Primary Biliary Cholangitis: A Call for Patient Engagement in Future Research
- International expert Delphi consensus on the management of metabolic dysfunction- and alcohol-associated liver disease (MetALD)
- Interpreting large esophageal varices as a predictor of hepatocellular carcinoma
- First-day clinical phenotyping in acute-on-chronic liver failure: a 24-hour landmark analysis with preliminary external reproducibility
- Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes
- Development and validation of a prediction model for acute kidney injury in cirrhosis with normal serum creatinine levels
- Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study
- Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event
- The impact of early allograft dysfunction severity on graft and recipient outcomes in pediatric liver transplantation
- Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis
- MRI imaging and machine learning based radiomics for detection of mixed HCC and CCA tumors
- PAI-1 as a modulator of the EMT-associated signaling pathway during HCV protein expression
- Longitudinal health-related quality of life and associated factors in autoimmune liver diseases
- A prospective cohort validation study of a multivariable algorithm ASAP for risk stratification of hepatocellular carcinoma surveillance
- The absence of the alpha-7 nicotinic acetylcholine receptor impairs liver regeneration due to altered autophagic response after resection
- Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis
- Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease
- Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation
- Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review
- Impact of adding statins to non-selective beta-blockers in cirrhosis with portal hypertension: a systematic review and meta-analysis of randomized controlled trials
- Alcohol-associated liver disease in the MENA region: A 16-country survey of healthcare provider perspectives
- Impact of Adiposity-Related Obesity Definitions on MAFLD/MASLD Framework
- Comment on “Endoscopy timing in managing acute esophagogastric variceal bleeding: a multicenter retrospective study”
- Tumor burden and early outcomes after first variceal bleeding in hepatocellular carcinoma: a clinically valuable signal, with some refinements
- ALEH position statement on the management of hepatitis B virus infection 2025
- Adult-to-adult living donor liver transplantation in a low-middle income country setting: eight-year experience from Colombia’s first program
- Acute-on-chronic liver failure designation in patients with severe alcohol-associated hepatitis undergoing liver transplantation
- Clinical features, treatment strategies and outcomes of hepatocellular carcinoma in association with type 1 Abernethy malformation: an evaluation of a pooled case series
- The global academic hepatology capacity index (GAHCI): a multi-source assessment reveals profound disparities across Latin America